Mersana Therapeutics, Inc. Payments for Restructuring
Mersana Therapeutics, Inc. reported Payments for Restructuring of $5.92 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2024-02-28
- Mersana Therapeutics, Inc. payments for restructuring for the quarter ending 2023-12-31 was $3.48M.
- Mersana Therapeutics, Inc. payments for restructuring for fiscal 2023 was $5.92M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|
| 2023-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.92M 10-K · filed 2024-02-28 | |
| 2023-09-30 | $2.44M 10-Q · filed 2023-11-07 |